期刊文献+

钾离子敏感试验与间质性膀胱炎PUF评分的相关性研究 被引量:1

Relationship of potassium sensitivity test and PUF in interstitial cystitis
原文传递
导出
摘要 目的探讨钾离子敏感试验(PST)与间质性膀胱炎(IC)盆腔疼痛和尿频、尿急症状(PUF)评分的相关性及意义。方法IC患者14例。女13例,男1例。平均年龄48岁。临床表现主要为尿频、尿急、膀胱充盈后耻骨上及会阴区疼痛。14例均依据美国糖尿病、消化及肾病协会(NIDDK)IC诊断标准确诊。采用膀胱水囊扩张后碳酸氢钠、利多卡因及肝素钠灌注治疗。治疗前后均行PST评分和PUF评分,并分析二者之间的关系。结果14例患者治疗前后PST评分中位数分别为4.0、1.0,PUF评分中位数分别为27.5、13.5,治疗前后差异均有统计学意义(P〈0.01)。PST评分与PUF评分呈正相关(治疗前rs=0.868,t=4.418,P=0.001;治疗后rs=0.779,t=4.300,P=0.001)。结论PST和PUF评分在IC中表现出一致性,可单独作为IC诊断、鉴别诊断、病情严重程度及治疗效果判定的重要指标。 Objective To discuss whether potassium sensitivity test(PST) is correlated with PUF in Interstitial Cystitis (IC). Methods The data of 14 IC patients (female 13, male 1) were analyzed. The mean age was 48 years (range 35-67 years). The clinical symptoms included urinary frequency, urgency, pelvic and peritoneal region pain after bladder filling. All the patients met the diagnostic criteria of NIDDK for IC. Dilatations by hyponome were performed, medicine including heparinsodium, lidocaine, NaHCO3 were used by intravesical instillation. PST and the pelvic pain and urgency/frequency patient symptom (PUF) were used for evaluation. The relationship of the PST and PUF was assessed by statistics. Results PST median decreased from 4.0 to 1.0 (P〈0.01). PUF median decreased from 27.5 to 13.5(P〈0.01). PST was directly correlated with PUF (rs =0. 868, t= 4. 418, P〈0. 001 before treatment, r5 = 0. 779, t=4. 300, P=0. 001 after treatment). Conclusions PST and PUF are correlated. Both can be used as index in diagnosis, differential diagnosis, symptom severity and treatment effectiveness evaluation of IC.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2009年第4期268-270,共3页 Chinese Journal of Urology
关键词 膀胱炎 间质性 钾离子敏感试验 PUF评分 相关性 Cystitis, interstitial Potassium sensitivity test PUF Dependablity
  • 相关文献

参考文献11

  • 1Parsons CL. Potassium sensitivity test. Tech Urol, 1996, 2: 171-173.
  • 2陈洪德,李澄棣.间质性膀胱炎钾离子敏感试验与肝素灌注治疗效果分析[J].中华泌尿外科杂志,2004,25(9):644-644. 被引量:3
  • 3Parson CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinize lidocaine in patients with interstitial cystitis. Urology, 2005, 65:45- 48.
  • 4Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology, 2007, 69(Suppl 4): 64-72.
  • 5Hanno PM, Landis JR, Matthe-Cook Y, et al. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database stud y. J Urol, 1999,161:553- 557.
  • 6Daha LK, Riedl CR, Hohbrugger G, et al. Comparative as sessment of maximal bladder capacity, 0.9M NaCl versus 0. 2M KCl, for the diagnosis of interstitial cystitis: a prospec tive controlled study. J Urol, 2003, 170: 807-809.
  • 7Parsons CL, Stein PC, Bidair M, et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. NeurourolUrodyn, 1994, 13: 515-520.
  • 8Parsons CL, Greenberger M, Gabal L, et al. The role of uri nary potassium in the pathogenesis and diagnosis of intersti tialcystitis. J Urol, 1998, 159:1862-1866.
  • 9Sairanen J, Tammela TL, I-eppilahti M, et al. Potassium sensitivity test (PST) as a measurement of treatment efficacy of pain ful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium. Neurourol Urodyn, 2007, 26:267 -270.
  • 10Teichman JM, Nielsen-Omeis BJ. Potassium leak test pre dicts outcome in interstitial cystitis. J Urol, 1999,161:1791- 1794.

二级参考文献3

  • 1Parsons CL, Benson G, Childs SJ, et al. A quantitatively controlled method to prospectively study interstitial cystitis and which demonstrates the effect of pentosanpolysulfate. J Urol, 1993,150: 845-848.
  • 2Parsons CL. Potassium sensitivity test. Tech Urol, 1996,2:171-173.
  • 3Hanno PM. Diagnosis of interstitial cystitis.Urol Clin North Am, 1994,21:63-66.

共引文献2

同被引文献10

  • 1朱震平,黄军成,张雪燕.阿米替林联合肝素膀胱灌注治疗间质性膀胱炎的疗效观察[J].广东医学院学报,2014,32(1):23-25. 被引量:3
  • 2王亮,陈昭颉,王庆堂,曹文峰,刘祥丹,陈卫国,汪俊超.肝素膀胱灌注治疗间质性膀胱炎[J].中华泌尿外科杂志,2004,25(9):625-626. 被引量:34
  • 3黄海,姚友生,许可慰,林天歆,郭正辉,谢文练,江春,韩金利,黄健.间质性膀胱炎治疗方案选择[J].广东医学,2007,28(4):591-592. 被引量:11
  • 4Gillenwater JY, Wein AJ. Summary of the National Institute of Ar- thritis, Diabetes, Digestive and Kidney Diseases Workshop on Inter- stitial Cystitis, National Institutes of Health, Bethesda, Maryland, Au- gust 28 - 29,1987 [ J]. J Urol, 1988,140( 1 ) :203 - 206.
  • 5van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, ran-domized, placebo controlled, double-blind study of amitfiptyline for the treatment of interstitial cystitis[ J]. J Urol,2004,172(2) :533 - 536.
  • 6Liu HT, Kuo HC. lntravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production andcontrol bladder pain in interstitial cystitis [ J ]. Urology ,2007,70 (3) :463 - 468.
  • 7Kuo HC,Chanceuor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydredistention alone for the treatment of refractory interstitial cystitis/painful bladder syn- drome [ J ]. BJU Int,2009,104 (5) :657 - 661.
  • 8Giannantoni A, Porena M, Costantini E, et al. Botulinum A toxin in- travesical injection in patients with painful bladder syndrome: 1 - year followup [ J ]. J Urol,2008,179 ( 3 ) : 1031 - 1034.
  • 9韩辉,周芳坚,王斌,李永红,秦自科,刘卓炜,陈晓峰.生活质量评分表在肠代膀胱功能评估中的应用研究[J].中华泌尿外科杂志,2008,26(6):411-414. 被引量:6
  • 10刘永达,袁坚,曾国华,雷鸣,罗金泰,张泽,钟惟德.膀胱水扩张术治疗氯胺酮相关性膀胱损害六例分析[J].中国综合临床,2012,28(7):746-748. 被引量:7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部